Tower Research Capital LLC (Trc) Wave Life Sciences Ltd. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,579 shares of WVE stock, worth $89,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,579
Previous 7,748
15.09%
Holding current value
$89,934
Previous $38,000
39.47%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$249 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$137 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$133 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$92.1 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$84.3 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.19B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...